These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24291969)

  • 61. Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis.
    Uzawa A; Kawaguchi N; Kanai T; Himuro K; Oda F; Yoshida S; Yoshino I; Kuwabara S
    J Neurol; 2015; 262(4):1019-23. PubMed ID: 25683765
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
    Sanders DB; Hart IK; Mantegazza R; Shukla SS; Siddiqi ZA; De Baets MH; Melms A; Nicolle MW; Solomons N; Richman DP
    Neurology; 2008 Aug; 71(6):400-6. PubMed ID: 18434638
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
    Hehir MK; Hobson-Webb LD; Benatar M; Barnett C; Silvestri NJ; Howard JF; Howard D; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; LaBoy SM; Fellman MA; Greene SM; Pasnoor M; Burns TM
    Neurology; 2017 Sep; 89(10):1069-1077. PubMed ID: 28801338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
    Burns TM; Sadjadi R; Utsugisawa K; Gwathmey KG; Joshi A; Jones S; Bril V; Barnett C; Guptill JT; Sanders DB; Hobson-Webb L; Juel VC; Massey J; Gable KL; Silvestri NJ; Wolfe G; Cutter G; Nagane Y; Murai H; Masuda M; Farrugia ME; Carmichael C; Birnbaum S; Hogrel JY; Nafissi S; Fatehi F; Ou C; Liu W; Conaway M
    Muscle Nerve; 2016 Dec; 54(6):1015-1022. PubMed ID: 27220659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.
    Lee I; Kaminski HJ; Xin H; Cutter G
    Muscle Nerve; 2018 Feb; ():. PubMed ID: 29466829
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.
    Dandona P; Corkan EJ; Sladen GE
    Postgrad Med J; 1977 Jun; 53(620):321-4. PubMed ID: 887530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early aggressive treatment strategy against myasthenia gravis.
    Nagane Y; Suzuki S; Suzuki N; Utsugisawa K
    Eur Neurol; 2011; 65(1):16-22. PubMed ID: 21116111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
    Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early fast-acting treatment strategy against generalized myasthenia gravis.
    Utsugisawa K; Nagane Y; Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M
    Muscle Nerve; 2017 Jun; 55(6):794-801. PubMed ID: 27603432
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.
    Bryant A; Atkins H; Pringle CE; Allan D; Anstee G; Bence-Bruckler I; Hamelin L; Hodgins M; Hopkins H; Huebsch L; McDiarmid S; Sabloff M; Sheppard D; Tay J; Bredeson C
    JAMA Neurol; 2016 Jun; 73(6):652-8. PubMed ID: 27043206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Long term administration of oral prednisone or prednisolone in treatment of myasthenia gravis. Report of five cases (author's transl)].
    Contamin F; Singer B; Mignot B; Offenstadt G; Ecoffet M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1213-8. PubMed ID: 216096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy].
    Hayashi M; Kimura N; Fukatsu A
    Nihon Jinzo Gakkai Shi; 2008; 50(5):581-7. PubMed ID: 18767486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Translation and validation of the 15-item Myasthenia Gravis Quality of life scale in Dutch.
    Strijbos E; Gärtner FR; Verschuuren JJ
    Muscle Nerve; 2018 Feb; 57(2):206-211. PubMed ID: 28271514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.
    Vrinten C; Lipka AF; van Zwet EW; Schimmel KJ; Cornel MC; Kuijpers MR; Hekster YA; Weinreich SS; Verschuuren JJ
    BMJ Open; 2015 Jul; 5(7):e007863. PubMed ID: 26185179
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis.
    Kawaguchi N; Yoshiyama Y; Nemoto Y; Munakata S; Fukutake T; Hattori T
    Curr Med Res Opin; 2004 Aug; 20(8):1269-73. PubMed ID: 15324529
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. II. PSL pharmacokinetics during intermittent treatment with PSL administration 4 consecutive days a week].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):675-94. PubMed ID: 3622862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.